The U.S. Food and Drug Administration held a Non-prescription Drug Advisory Committee meeting last week to discuss the effectiveness of oral phenylephrine as an active ingredient in over-the-counter cough and cold products that are indicated for the temporary relief of congestion, both as a single-ingredient product and in combination with other ingredients.
FDA solicits public comments on phenylephrine-based decongestants
